Anti-CD19 CAR-NK Cells in Refractory/Relapsed Systemic Lupus Erythematosus
Status:
RECRUITING
Trial end date:
2026-05-31
Target enrollment:
Participant gender:
Summary
This study is a single-center, open-label, single-arm trial. The aim of this study is to investigate the safety and efficacy of anti-CD19 CAR-NK cells in patients with refractory/relapsed systemic lupus erythematosus.
Phase:
PHASE1
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University